In fetuses with lower urinary tract obstruction (LUTO), the renin-angiotensin system (RAS) is activated because of renal changes. The potential cardiac remodelling due to renal dysfunction and RAS activation may have an impact on myocardial function (MF). The aim of the study was to identify possible differences in MF in LUTO fetuses compared to healthy controls and to investigate possible interactions between urine biochemistry and MF indices. Methods: This is a retrospective study consisting of 24 LUTO fetuses and 37 healthy controls. Gestational age was similar distributed in both groups. The systolic tricuspid (TAPSE) and mitral valve ring excursion (MAPSE) were determined. Myocardial velocities were measured using pulsed wave tissue Doppler imaging (PW-TDI). In addition, the E'/A' ratio as a parameter of ventricular compliance and the myocardial performance index (MPI') were calculated for both ventricles. Results: Right ventricular (RV) E'/A' ratio was significantly lower in LUTO fetuses compared to healthy controls (0.57 versus. 0.62, p=0.02). A significantly lower RV MPI' was observed in the LUTO group (0.51 versus. 0.61, p=0.003). In contrast to healthy controls LUTO fetuses showed significantly lower MAPSE values (4.3 mm versus. 5.5 mm, p=0.006). TAPSE was also reduced in LUTO fetuses, but without reaching statistical significance (5.9 mm vs. 6.6 mm, p=0.113). Correlation between MF indices and fetal urine biochemistry revealed a significant positive correlation between RV E'/A' ratio and ß-2-microglobulin (r=0.56, p=0.01) as well as α-1-microglobulin (r=0.65. p=0.005).
Conclusions:
We observed differences in MF in LUTO fetuses compared to healthy controls. This can be understood as a sign of intrauterine cardiac remodelling. Furthermore, a link between ventricular compliance and renal protein secretion has been identified. Our results should be confirmed by prospective studies with larger case series. Objectives: Neurodevelopmental delay is frequently encountered in children with congenital heart defects (CHD). Recent cohorts show slightly smaller head circumferences (HC) in isolated CHD, irrespective of type of CHD, altered cerebral flow or brain * This presentation is eligible for the Young Investigator award (to be presented in the closing plenary).
oxygenation. This study compares HC in non-isolated and isolated CHD cases to evaluate the effect of additional pathology on head size. Methods: All prenatally diagnosed CHD cases were selected from our regional PRECOR registry (2002-present) . Cases with multiple pregnancy, diabetes, severe structural brain anomalies or functional CHD were excluded. Cases were allocated to the isolated group or according to the type of pathology assigned to 1 of the 3 non-isolated groups: genetic diagnosis, extra-cardiac structural malformation or placental insufficiency. HC z-scores between isolated and non-isolated subjects were compared using a mixed-linear regression model at 20 weeks and over time, based on the mean increase or decrease. Results: We included 915 prenatally diagnosed CHD cases (379 (41,4%) non-isolated). At 20-weeks non-isolated cases had significantly lower HC z-scores (z= -0.69 versus -0.02; p<0.000) and during pregnancy a larger decrease in head growth was shown (z= -0.03 versus -0.01 SD per week; p=0.01) compared to isolated cases. The placental pathology group (N=38) had the smallest HC z-score (z= -1.24) and largest decrease in head growth (-0.05 SD/week) at 20 weeks and thereafter subjects with a genetic diagnosis (HC z-score=-0.72; -0.04 SD/week). Abdominal circumference (AC) z-scores were also significantly lower in non-isolated fetuses.
The significantly smaller HC amongst CHD cases appears to be strongly associated with additional pathology. Genetic syndromes seem to play a less important role than placental insufficiency. This study shows that developmental pathways involved in both cardiogenesis as in overall growth may partly explain the earlier reported small HCs in CHD cases and may have an effect on neurodevelopment.
